References for Smoking and CAD Paper
HOME
BACK TO SMOKING PAPER
References 1. Fuster V, Badimon L, Badimon JJ, Chestebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50. 2. Schoen FJ. Blood Vessels. In: Pathologic basis of disease -5th ed. Cotran RS, Kumar V, Robbins SL, eds. Philadelphia: W.B. Saunders Co., 1994:467-89. 3. Brown MS, Goldstein JL. Scavenging for receptors. Nature 1990;343:508-9. 4. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotiens. J Biol Chem 1989;264:2599-66. 5. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AAAD, Lusis AJ. Atherosclerosis: basic mechanisms oxidation, inflammation, and genetics. Circulation 1995;91:2488-96. 6. Jialal III, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemical perspective. Clin Biochem 1996;42:498-506. 7. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and morality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53 (Suppl) 326S-34S. 8. Jialal I, Grundy SM. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta-carotene on low-density lipoprotein oxidation. Circulation 1993;88:2780-6. 9. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:899-906. 10. Wilson RB, Middleton CC, Sun GY. Vitamin E antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits. J Nutr 1978;108:1858-67. 11. Avogaro P, Bittlol-Bon G, Cazzolato G. Presence of a modified low density 12. Codandabany U. Erythrocyte lipid peroxidation and antioxidants in cigarette smokers. Cell Biochem Funct 2000;18(2):99-102. 13. Zhou JF, Yan XF, Gou FZ, Sun NY, Qian ZJ, Ding DY. Effects of cigarette smoking and smokinf cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed Environ Sci 2000;13(1):44-55. 14. Bui MH, Sauty A, Collet F, Leuenberger P. Dietary vitamin C intake and concentrations in the body fluids and cells of male smokers and non-smokers. J Nutr 1992;122(2):312-6. 15. Brown KM, Morrice PC, Duthie GG. Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and non-smokers: dose response to vitamin E supplementation. Am J Clin Nutr 1997;65:496-502. 16. Ayaori M, Hisada T, Suzukawa M, Yoshida H, Nishiwaki M, Ito T, Nakajima K, Higashi K, Yonemura A, Ohsuzu F, Ishikawa T, Nakamura H. Plasma levels and redox status of ascorbic acid and levels of lipid peroxidation products in active and passive smokers. Environ Health Perspect 2000;108(2):105-8. 17. Robinson JP, Switzer P, Ott W. Daily exposure to environmental tobacco smoke: smokers vs non-smokers in California. Am J Public Health 1996;86(9):1303-5. 18. Husgafvle-Pursiainen K, Sorsa M, Engstrom K, Einisto P. Passive smoke at work: biochemical and biological measures of exposure to environmental tobacco smoke. Int Arch Occup Environ Health 1987;59(4):337-45. 19. Tribble DL, Giuliano LJ, Fortmann SP. Reduced plasma ascorbic acid concentrations in smokers regularly exposed to environmental tobacco smoke. Am J Clin Nutr 1993;58(6):886-90. 20. Celemajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334(3):150-4. 21. Neuteufl T, Priglinger U, Heher S, Zehetgruber M, Sorgei G, Lehr S, Huber K, Maurer G, Weidinger F, Kostner K. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 2000;35(2):277-83. 22. Moffatt RJ, Stamford BA, Biggerstaff KD. Influence of worksite environmental tobacco smoke on serum lipoprotein profiles of female non-smokers. Metabolism 1995;44(12):1536-9. 23. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated moncytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93(8):1488-92. 24. James RW, Leviev I, Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentrations in patients with coronary artery disease. Circulation 2000;101(19):2252-7. 25. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation 1993;88(4 Pt 1):1820-5. 26. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol 1994;24(2):546-54. 27. Sanner T, Dybing E. Health damages from passive smoking. Tidsskr Nor Laegeforen [article in Norwegian] 1996;116(5):617-20. 28. Lam TH, He Y. Passive smoking and coronary heart disease: a brief review. Clin Exp Pharmacol Physiol 1997;24(12):993-6. 29. Kritz H, Schmid P, Sinzinger H. Passive smoking and cardiovascular risk. Arch Intern Med 1995;155(18):1942-8. 30. Steenland K. Passive smoking and the risk of heart disease. JAMA 1992;267(1):94-9. 31. Garland C, Barrett-Conner E, Suarez L, Criqui MH, Wingard DL. Effects of passive smoking on ischemic heart disease mortality of non-smokers. A prospective study. Am J Epidemiol 1985;121(5):645-50. 32. Thun M, Henley J, Apicella L. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect 1999;107 Suppl 6:841-6. 33. Muscat JE, Wynder EL. Exposure to environmental tobacco smoke and the risk of heart attack. Int J Epidemiol 1995;24(4):715-9. 34. Steenland K, Thun M, Lally C, Heath C Jr. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation 1996;94(4):622-8. 35. Steenland K. Risk assessment for heart disase and workplace ETS exposure among non-smokers. Environ Health Perspect 1999;107 suppl 6:859-63. 36. Kawachi I, Pearce NE, Jackson RT. Deaths from lung cancer and ischemic heart disease due to passive smoking in New Zealand. N Z Med J 1989;102(871):337-40. 37. Gori GB. Environmental tobacco smoke and coronary heart syndromes: absence of an association. Regul Toxicol Pharmacol 1995;21(2):281-95. 38. Smith CJ, Fischer TH, Sears SB. Environmental tobacco smoke, cardiovascular disease, and the nonlinear dose-response hypothesis. Toxicol Sci 2000;54(2):462-72. 39. Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemilogy, physiology, and biochemistry. Circulation 1991;83(1):1-12.
